Australia
Australia Peritoneal Dialysis Solutions Market Industry Trends and Forecast to 2034: Segmented by (Product, Mode, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Australia · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
China at $352.8 Mn.
India at 9.3% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$57.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $58.2 Mn | — | — |
| 2025 (base) | $62.5 Mn | +$4.4 Mn | — |
| 2026 (forecast) | $67.2 Mn | +$4.7 Mn | +7.5% |
| 2027 (forecast) | $72.2 Mn | +$5.0 Mn | +15.6% |
| 2028 (forecast) | $77.7 Mn | +$5.4 Mn | +24.2% |
| 2029 (forecast) | $83.5 Mn | +$5.8 Mn | +33.5% |
| 2030 (forecast) | $89.8 Mn | +$6.3 Mn | +43.6% |
| 2031 (forecast) | $96.5 Mn | +$6.7 Mn | +54.3% |
| 2032 (forecast) | $103.7 Mn | +$7.2 Mn | +65.9% |
| 2033 (forecast) | $111.5 Mn | +$7.8 Mn | +78.3% |
| 2034 (forecast) | $119.9 Mn | +$8.4 Mn | +91.7% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$1.57 Bn
China
$352.8 Mn
Canada
$329.2 Mn
Japan
$289.6 Mn
Germany
$160.6 Mn
France
$125.2 Mn
UK
$107.4 Mn
Brazil
$102.4 Mn
Spain
$97.1 Mn
Italy
$96.2 Mn
India
$96.6 Mn
Ecuador
$91.2 Mn
Saudi Arabia
$75.1 Mn
Mexico
$69.6 Mn
Australia (this report)
$62.5 Mn
New Zealand
$49.9 Mn
Russia
$47.3 Mn
South Africa
$30.5 Mn
UAE
$22.6 Mn
Egypt
$13.1 Mn
Philippines
$9.5 Mn
Hong Kong
$8.1 Mn
Malaysia
$7.9 Mn
Singapore
$5.6 Mn
Thailand
$4.7 Mn
Kenya
$2.9 Mn
Peritoneal dialysis solutions are sterile fluids used to clean the blood through the belly lining in home dialysis.
Key segments of the peritoneal Dialysis Solutions market include product (Glucose-Based Solutions, Icodextrin Solutions and Amino Acid Solutions) and mode (Continuous Ambulatory PD and Automated PD).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the peritoneal Dialysis Solutions market.
Ready-to-use formulations, biosimilars and supply security programmes give the peritoneal Dialysis Solutions market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the peritoneal Dialysis Solutions market.
The peritoneal Dialysis Solutions market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for peritoneal Dialysis Solutions. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Australia.
What doctors and scientists are doing in Peritoneal Dialysis Solutions right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Australia
Australia
Australia
Australia
Australia
Australia
Healthcare Services · Australia
Digital Health · Australia
Medical Devices · Australia
Digital Health · Australia
Medical Devices · Australia
Digital Health · Australia